Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma.
Reads0
Chats0
TLDR
The depth of invasion was studied using the criteria for staging of Clark et al.2 to see if maximal cross-sectional area, thickness, stage of invasion, or a combination of these can be of value in assessing the prognosis of cutaneous melanoma.Abstract:
CuTANEous melanoma is a most unpredictable lesion. The marked variation in prognosis is probably a function of many variables, one of which is the size of the tumor. Though there is a roughly inverse relationship between the diameter of the lesion and survival,5 very small lesions have recurred or metastasized. One possible reason for the lack of reliability of tumor size in estimating prognosis may be that studies to date have considered size in only two diamensions and have neglected tumor volume. Two melanomas can have the same diameter but differ greatly in thickness because of variation in either depth of invasion or degree of protrusion from the surface of the skin or both. A recent study 2 has shown that prognosis correlates well with staging of the depth of invasion, but there have been no studies relating survival to tumor volume. To measure tumor volume it is necessary to know the surface area of the tumor, but in this retrospective study we only know the maximal diameters of the lesions. By measuring the maximal thickness of the lesions we can calculate the maximal crosssectional area, which should be roughly proportional to the volume of the tumor. The depth of invasion was also studied using the criteria for staging of Clark et al.2 to see if maximal cross-sectional area, thickness, stage of invasion, or a combination of these can be of value in assessing the prognosis of cutaneous melanoma. A total of 98 lesions were so studied.read more
Citations
More filters
Journal ArticleDOI
Sentinel-Lymph-Node Biopsy for Cutaneous Melanoma
TL;DR: In a patient with cutaneous melanoma, a sentinel-lymph-node biopsy is performed with the aid of a handheld gamma scanner and the use of isosulfan blue dye.
Journal ArticleDOI
Serum S-100b protein as a prognostic marker in malignant cutaneous melanoma
E. Djureen Mårtenson,L O Hansson,B. Nilsson,E. von Schoultz,E. Månsson Brahme,Ulrik Ringborg,Johan Hansson +6 more
TL;DR: This investigation contains the largest material of patients so far analyzed with the new LIA assay of S- 100B protein in serum and confirms that S-100Bprotein in serum is correlated with clinical stage and is an independent prognostic marker in clinical stages II and III.
Journal ArticleDOI
Polymerase Chain Reaction-Based Detection of Circulating Melanoma Cells as an Effective Marker of Tumor Progression
Giuseppe Palmieri,Maria Strazzullo,Paolo A. Ascierto,Sabrina M.R. Satriano,Antonio Daponte,Giuseppe Castello +5 more
TL;DR: In this paper, the authors evaluated the clinical significance of the presence in peripheral blood of specific PCR-positive mRNA markers as an expression of circulating melanoma cells and found that although detected at various levels among assessable patients, each mRNA marker was significantly correlated with disease stage.
Journal ArticleDOI
In vivo photoacoustic microscopy of human cutaneous microvasculature and a nevus
TL;DR: The presented images demonstrate the potential of PAM to aid in the study and evaluation of cutaneous microcirculation and analysis of pigmented lesions and can have a clinical impact in diagnosis and assessment of systemic diseases that affect the microvasculature such as diabetes and cardiovascular disease.
Journal ArticleDOI
Melanoma and Tumor Thickness Challenges of Early Diagnosis
Marie Aleth Richard,Jean-Jacques Grob,Marie-Françoise Avril,Michèle Delaunay,Xavier Thirion,Pierre Wolkenstein,Pierre Souteyrand,Brigitte Dréno,Jean Jacques Bonerandi,Sophie Dalac,Laurent Machet,Jean Claude Guillaume,Jacqueline Chevrant-Breton,Catherine Vilmer,François Aubin,Bernard Guillot,Marie Beylot-Barry,Catherine Lok,Nadia Raison-Peyron,Philippe Chemaly +19 more
TL;DR: Poor prognosis can be accounted for by aggressive rapidly growing tumors rather than by delays, and campaigns for early diagnosis of melanoma may no longer have a major impact on prognosis, unless they are focused on subgroups less accessible to information and medical care.
References
More filters
Journal ArticleDOI
Some Methods for Strengthening the Common χ 2 Tests
TL;DR: In this article, the authors discuss two kinds of failure to make the best use of x2 tests which I have observed from time to time in reading reports of biological research, and propose a number of methods for strengthening or supplementing the most common uses of the ordinary x2 test.
Journal Article
The Histogenesis and Biologic Behavior of Primary Human Malignant Melanomas of the Skin
TL;DR: Evidence is presented suggesting that superficial spreading melanoma and lentigo maligna melanoma (Hutchinson9s melanotic freckle) show a long period of superficial growth, followed by the relatively rapid appearance of nodules or deeper invasion within the primary lesion.
Journal ArticleDOI
The Detection of Partial Association, I: The 2 × 2 Case
TL;DR: In this article, a criterion for testing null hypotheses of conditional independence of two dichotomous random variables is derived for testing whether the association of the two random variables in the conditional distribution is, in a certain sense, constant.
Journal ArticleDOI
Clinicopathological correlations in a series of 117 malignant melanomas of the skin of adults.
Related Papers (5)
The Histogenesis and Biologic Behavior of Primary Human Malignant Melanomas of the Skin
Final Version of the American Joint Committee on Cancer Staging System for Cutaneous Melanoma
Charles M. Balch,Antonio C. Buzaid,Seng Jaw Soong,Michael B. Atkins,Natale Cascinelli,Daniel G. Coit,Irvin D. Fleming,Jeffrey E. Gershenwald,Alan Houghton,John M. Kirkwood,Kelly M. McMasters,Martin F. Mihm,Donald L. Morton,Douglas S. Reintgen,M. I. Ross,Arthur J. Sober,John A. Thompson,John F. Thompson +17 more
Final Version of 2009 AJCC Melanoma Staging and Classification
Charles M. Balch,Jeffrey E. Gershenwald,Seng-Jaw Soong,John F. Thompson,Michael B. Atkins,David R. Byrd,Antonio C. Buzaid,Alistair J. Cochran,Daniel G. Coit,Shouluan Ding,Alexander M.M. Eggermont,Keith T. Flaherty,Phyllis A. Gimotty,John M. Kirkwood,Kelly M. McMasters,Martin C. Mihm,Donald L. Morton,Merrick I. Ross,Arthur J. Sober,Vernon K. Sondak +19 more
Prognostic Factors Analysis of 17,600 Melanoma Patients: Validation of the American Joint Committee on Cancer Melanoma Staging System
Charles M. Balch,Seng Jaw Soong,Jeffrey E. Gershenwald,John F. Thompson,Douglas S. Reintgen,Natale Cascinelli,Marshall M. Urist,Kelly M. McMasters,M. I. Ross,John M. Kirkwood,Michael B. Atkins,John A. Thompson,Daniel G. Coit,David R. Byrd,Renee A. Desmond,Yuting Zhang,Ping-Yu Liu,Gary H. Lyman,Aberto Morabito +18 more